Categories: Financials

AGP Limited (AGP) Q1 earnings preview

TSL Research has just released an update on AGP’s previous quarter’s financial results. Here are the important points from their 1QCY24 earnings preview.

Strong Growth in Profitability

AGP is expected to report an EPS of PKR 2.25 and a Profit After Tax (PAT) of approximately PKR 739 million for 1QCY24, marking an impressive increase of around 77% over the same period last year.

Revenue Analysis

The company’s revenue is projected to reach around PKR 3.9 billion for 1QCY24. This growth is attributed to a price increase of 14% and 20% for essential and non-essential medicines, respectively. Additionally, AGP is anticipated to receive marginal support from exports, with a notable 20%QoQ growth in 1QCY24.

Gross Margin Expectations

Despite strong revenue growth, gross margins are expected to decline to 53.2% for 1QCY24, down 4 percentage points QoQ due to increased energy prices.

Future Outlook

AGP is expected to benefit from the pending deregulation of non-essential medicines and the Government’s decision to increase prices of 146 essential medicines. Given its current revenue mix of 40% essential and 60% non-essential medicines, the company is well-positioned for future growth.

Dividend Expectations

No interim cash dividend announcement is anticipated for the quarter.

PKR Mn1QCY23A1QCY24EYoY4QCY23AQoQ
Revenue3,8996,40764%5,80410%
Cost of sales1,8632,99661%2,47921%
Gross profit2,0363,41168%3,3253%
Selling, admin & marketing expenses1,2531,93254%1,70713%
Other expenses/(income) – net12331-75%102.0x
Finance costs1433781.6x647-42%
Profit before tax5171,0711.1x96012%
Taxation1223321.7x26426%
Profit after tax39673987%6956%
Profit attributable to Parent Co.35662977%5926%
EPS – Consolidated1.272.252.12
DPS2.00
Source: TSL Research & Company Reports

These numbers provide insights into AGP’s anticipated financial performance for the first quarter of CY24, reflecting strong growth in revenue and profitability.


Disclaimer:

The information in this article is based on research by TSL Research & Company Reports. All efforts have been made to ensure the data represented in this article is as per the research report. This report should not be considered investment advice. Readers are encouraged to consult a qualified financial advisor before making any investment decisions.

KSEStocks News

Recent Posts

Shifa International (SHFA) has returned 150% in two months, will the rally continue?

Shifa International (SHFA) has already rallied 150%, but there is still more upside to the…

2 weeks ago

HUBC’s base plant expiry: What is next for the power giant?

The closure of the Hub Power Company Limited (HUBC) plant marks a significant shift in…

2 months ago

How well did Fatima Fertiliser perform in 2QCY24?

Fatima's 2QCY24 financial performance reflects a challenging quarter, marked by a significant decline in profitability…

3 months ago

How is HMB handling financial challenges to grow?

Habib Metropolitan Bank Limited (HMB) recently released its second-quarter results for 2024, revealing a mixed…

3 months ago

How does MARI and POL reserve life compare?

In the oil and gas sector, the longevity of reserves is a critical measure of…

3 months ago

Is Cherat Cement poised for growth?

Cherat Cement Company Limited (CHCC) has recently released its financial results for the fourth quarter…

3 months ago